A Dutch study revealed that a DNA test to screen for human papillomavirus, which can lead to cervical cancer, helped spot 50% more of the potentially precancerous lesions compared with a Pap smear. Researchers believe the test will pave the way for early treatment of dangerous lesions and fewer screenings for women.

Full Story:

Related Summaries